JPJanice L. Pringle

Janice L. Pringle

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Janice L. Pringle has a total of 65 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Project Lifeline–II: Feasibility of Implementing Screening, Brief Intervention, and Referral to Treatment (SBIRT) in Allegheny County, Pennsylvania

    by Renee M. Cloutier, William N. Dowd, Arnie Aldridge, Caitlin A. Walsh, Brett A. Messman, Jessica L. Northcott, Abigail Talbert, Chronis Manolis, Vanessa Campbell, Janice L. Pringle

    Objectives: US community pharmacies are a unique and underused health service setting for identifying and potentially intervening with patients at risk of opioid overdose or opioid use disorder with evidence-based practices such as screening, brief intervention, and referral to treatment (SBIRT). The aim of our study was to assess the feasibility of implementing SBIRT in community pharmacies in an urban county in terms of engagement, reach, and equity across the cascade of pharmacy screening and care. Methods: Patients aged 18 years or older receiving a schedule II or III opioid prescription at 1 of 17 participating community pharmacies in Allegheny County, Pennsylvania, were invited to engage in SBIRT as part of Project Lifeline–II from June 2020 through January 2023. Participants completed a prescreen and/or a full screen. We calculated the percentage of patients who participated across the cascade of pharmacy screening and care, overall and by sex (male and female) and race (Black and White). Results: During the study period, 1952 unique adults (79.6%) were screened at least once (52.1% female; 58.0% White, 30.7% Black). Patients who identified as male (vs female) and Black (vs White) were more likely to have a positive prescreen (14.7% male vs 9.8% female; 16.4% Black vs 9.5% White), receive and complete a full screen (82.7% male vs 80.0% female; 83.6% Black vs 78.4% White), and score positively on the full screen (26.6% male vs 20.4% female; 26.8% Black vs 21.9% White). Conclusion: Although additional research is needed to characterize the full effect of Project Lifeline–II on patient outcomes, our findings help reinforce the benefits of multipronged public health initiatives that include community pharmacists to address the substance use disorder crisis in the United States.

  • Project lifeline: implementing SBIRT in rural pharmacies to address opioid overdoses and substance use disorder

    by Renee M. Cloutier, Abigail Talbert, Joseph Weidman, Janice L. Pringle

    Background: There is emerging recognition of the unique benefits of implementing screening, brief intervention, and referral to treatment (SBIRT) in pharmacy settings to identify patients who can benefit from services and connecting them to those services. Objectives: This study describes Project Lifeline – a multipronged public health initiative to provide educational and technical support to rural community pharmacies implementing SBIRT for substance use disorder (SUD) and providing harm reduction support. Methods: Eight community pharmacies were recruited. Patients receiving a Schedule II prescription were invited to engage in SBIRT and offered naloxone. Patient screening data and key informant interviews with pharmacy staff on implementation strategy were analyzed. Results: Between 2018–2020, 4,601 adult patients were offered screens and 3,407 screens were completed on 2,881 unique adult patients (51.3% female; n = 372). Key informant interviews highlighted the importance of person-centered staff education, role-playing, anti-stigma training, and integrating activities into existing patient-care processes. Conclusion: While ongoing research is needed to characterize the full impact of Project Lifeline on patient outcomes, the reported findings help reinforce the benefits of multipronged public health initiatives that include community pharmacists to address the SUD crisis.


  • Open Access

    Strategies to recruit rural primary care providers to implement a medication for opioid use disorder (MOUD) focused integrated care model

    by Renee M. Cloutier, Evan S. Cole, Brianna L. McDonough, Daniel A. Lomauro, John P. Miller, Abigail L. Talbert, Todd M. Bear, Nora C. Bridges, Abigail L. Foulds, Rachel Taber, et al.

    Background: Access to providers and programs that provide medications for opioid use disorder (MOUD) remains a systemic barrier for patients with opioid use disorder (OUD), particularly if they live in rural areas. The Rural Access to Medication Assisted Treatment (MAT) in Pennsylvania Project (Project RAMP) addressed this problem with a multisystem partnership that recruited, trained, and supported rural primary care providers to provide MOUD and implement an integrated care model (ICM) for patients with OUD. Given the demonstrated efficacy of Project RAMP, this article summarizes our recruitment strategies, including feasibility concerns for further expansion into other regions. Methods: The approach for recruiting implementation sites included two phases: partner outreach and site identification. Once recruited, the Systems Transformation Framework guided planning and implementation activities. Recruitment and implementation activities were assessed with implementation trackers and evaluated by providers via key informant interviews (KIIs). Results: Project RAMP recruited 26 primary care practices from 13 counties, including nine health systems and two private practice groups—exceeding the original target of 24 sites. There was a median of 49 days from first contact to project onboarding. A total of 108 primary care practices spanning 22 health systems declined participation. Findings from the KIIs highlighted the value of engaging PCPs by connecting to a shared vision (i.e., improving the quality of patient care) as well as addressing perceived participation barriers (e.g., offering concierge technical assistance to address lack of training or resources). Conclusion: Findings highlight how successful recruitment activities should leverage the support of health system leadership. Findings also emphasize that aiding recruitment and engagement efforts successfully addressed prescribers’ perceived barriers to providing MOUD as well as facilitating better communication among administrators, PCPs, behavioral health professionals, care managers, and patients. Plain Language Summary: Opioid use disorder (OUD) is one of the leading causes of preventable illness and death. The standard of care for OUD is the provision of medications for opioid use disorder (MOUD) and the application of an integrative integrated care model (ICM) where behavioral health is blended with specialized medical services. Unfortunately, access to providers and healthcare facilities that provide MOUD or apply an ICM remains a systemic barrier for patients with OUD, particularly if they live in rural areas. Although there is no one-size-fits-all approach to implementing MOUD in primary care, findings from Project The Rural Access to Medication Assisted Treatment (MAT) in Pennsylvania Project (Project RAMP) highlight strategies that may improve future MOUD and ICM implementation efforts in similar rural contexts. Specifically, future efforts to increase MOUD capacity by recruiting new providers should be prepared to leverage health system leadership, address provider barriers via training and expert consultation, and facilitate connections to local behavioral health providers. This approach may be helpful to others recruiting health systems and primary care practices to implement new care models to use MOUD in treating patients with OUD.


  • Open Access

    Rural access to MAT in Pennsylvania (RAMP): a hybrid implementation study protocol for medication assisted treatment adoption among rural primary care providers

    by Gerald Cochran, Evan S. Cole, Jack Warwick, Julie M. Donohue, Adam J. Gordon, Walid F. Gellad, Todd Bear, David Kelley, Ellen DiDomenico, Jan Pringle

    The continued escalation of opioid use disorder (OUD) calls for heightened vigilance to implement evidence-based care across the US. Rural care providers and patients have limited resources, and a number of barriers exist that can impede necessary OUD treatment services. This paper reports the design and protocol of an implementation study seeking to advance availability of medication assisted treatment (MAT) for OUD in rural Pennsylvania counties for patients insured by Medicaid in primary care settings. This project was a hybrid implementation study. Within a chronic care model paradigm, we employed the Framework for Systems Transformation to implement the American Society for Addiction Medicine care model for the use of medications in the treatment of OUD. In partnership with state leadership, Medicaid managed care organizations, local care management professionals, the Universities of Pittsburgh and Utah, primary care providers (PCP), and patients; the project team worked within 23 rural Pennsylvania counties to engage, recruit, train, and collaborate to implement the OUD service model in PCP practices from 2016 to 2019. Formative measures included practice-level metrics to monitor project implementation, and outcome measures involved employing Medicaid claims and encounter data to assess changes in provider/patient-level OUD-related metrics, such as MAT provider supply, prevalence of OUD, and MAT utilization. Descriptive statistics and repeated measures regression analyses were used to assess changes across the study period. There is an urgent need in the US to expand access to high quality, evidence-based OUD treatment—particularly in rural areas where capacity is limited for service delivery in order to improve patient health and protect lives. Importantly, this project leverages multiple partners to implement a theory- and practice-driven model of care for OUD. Results of this study will provide needed evidence in the field for appropriate methods for implementing MAT among a large number of rural primary care providers.


  • Open Access

    The Pennsylvania Prescription Drug Monitoring Program: Reducing the Misuse of Prescription Opioids

    by Lynn S. Mirigian, Laura A. Hendrick, Janice L. Pringle, Michael A. Zemaitis

    In 2016, 4,642 Pennsylvanians died from a drug overdose and 85% of these deaths were due to an opioid overdose (U.S. Drug Enforcement Administration and University of Pittsburgh School of Pharmacy 2017). With a 37% increase in deaths from 2015, the Commonwealth’s response to this epidemic has come from several fronts. One valuable resource has been the modernization and implementation of Pennsylvania’s Prescription Drug Monitoring Program (PDMP). PDMPs are state-­run programs that record dispensing of most controlled substances and provide this data to physicians and pharmacists (among others) to inform their practice about possible opioid use disorder by a given patient. This article discusses the role of Pennsylvania’s PDMP in patient care and law enforcement to reduce opioid overdoses in the Commonwealth. Recent evidence is discussed that demonstrates the effectiveness of state-­run PDMPs and their impact on opioid misuse and prescribing patterns. It is important to note that additional research into the effectiveness of PDMPs in preventing opioid-­related morbidity and mortality is needed.


  • Clinical Screening, Brief Intervention, and Referral to Treatment Proficiency Checklist

    by Janice L. Pringle, J. Paul Seale, Sylvia Shellenberger, Kim M. Grasso, Alicia Kowalchuk, Larry Laufman, James H. Bray, Arnie Aldridge

  • The pharmacist's role in overdose: Using mapping technologies to analyze naloxone and pharmacy distribution

    by Allison Burrell, Laken Ethun, Jaime Allen Fawcett, Sherry Rickard-Aasen, Karl Williams, Shannon M. Kearney, Janice L. Pringle


  • Integrating the Integrated: Merging Integrated Dual Diagnosis Treatment (IDDT) with Housing First

    by Janice Pringle, Kim Grasso, Lisa Lederer

    This study reports on a housing program that merged two evidence-based practices frequently applied in tandem: Integrated Dual Diagnosis Treatment and Housing First. Quantitative measures show that consumers in the program were receptive to supportive housing and core services. These quantitative measures, when considered alongside qualitative interviews, suggest that in order for more consumers to move through the IDDT stages of educational and vocational advancement, the staff will need to emphasize the permanence of supportive housing. Thus, the study also demonstrates the importance of integrating results of qualitative evaluations with quantitative data to strengthen a program’s evidence base.